Dr. Joshua Graff Zivin's research to date has
centered on the importance of uncertainty and
heterogeneity on individual and societal
decision-making. In the area of environmental
regulation and public health, he has focused primarily
on the use of targeted policies to achieve
environmental health objectives. He has also written
numerous articles applying his methodological expertise
in the area of health economics and medical
decision-making, with a recent focus on infectious
diseases. His publications have appeared in a wide
range of economic policy, and medical journals. Dr.
Graff Zivin is principal investigator for an
AHRQ-funded project to develop cost-effectiveness
methodologies that can adequately reflect preferences
regarding current and intertemporal uncertainty and the
director of the Merck-sponsored Columbia-Stanford
Consortium on Medical Innovation. He is also a faculty
research fellow at the National Bureau of Economic
Research.EDUCATION
| Rutgers University, New
Brunswick, NJ |
B.A. |
1993 |
Economics and Psychology |
| University of California,
Berkeley, CA |
M.S. |
1994 |
Ag and Resource Economics |
| University of California,
Berkeley, CA |
Ph.D. |
1998 |
Ag and Resource Economics |
PROFESSIONAL EXPERIENCE
| 1998-present |
Assistant
Professor, Department of Health Policy and
Management, Joseph Mailman School of Public
Health and Division of Surgery, Columbia
College of Physicians and Surgeons, Columbia
University, New York, NY |
| 1998-present |
Senior Research
Fellow, International Center for Health
Outcomes and Innovation Research, Columbia
University, New York, NY |
| 1998-2001 |
Health Services
Research Symposium Planning Committee, Greater
New York Hospital Foundation, New York, NY |
| 1998-present |
Director,
Effectiveness and Outcomes Research Program,
Columbia University, New York, NY |
| 2000-present |
Referee Panel,
NHS R&D Health Technology Assessment Programme |
| 2001-present |
Editorial Board,
Medical Spectator |
| 2002-present |
Secretariat
Member, MTCT Plus Initiative |
| 2002-present |
Co-Founder and
Executive Committee Member, Center for Economy,
Environment, and Society, Earth Institute,
Columbia University, New York, NY |
| 2002-present |
Director,
Columbia Stanford Consortium on Medical
Innovation, New York, NY |
| 2003-present |
Faculty Research
Fellow, National Bureau of Economic Research,
Cambridge, MA |
| 2003-2004 |
Senior Economist,
White House Council of Economic Advisers,
Washington, DC |
HONORS AND AWARDS
| 1989 |
Rutgers Deans'
Summer Scholar, Rutgers University |
| 1991-1993 |
Edward
Bloustein Distinguished Scholar, Rutgers
University |
| 1997 |
Outstanding
Graduate Student Instructor Award, University
of California, Berkeley |
| 2000 |
Outstanding
Journal Article: American Journal of
Agricultural Economics |
| 2003 |
Calderone
Junior Faculty Research Prize, Columbia
University |
PUBLICATIONS
Moskowitz, A., Williams, D., Tierney, A., Levitan, R.,
Zivin, J., & Gelijns, A. (1999). Economic
considerations of left ventricular assist device (LVAD)
implantation. In M. Oz, & D. Goldstein (Eds.), Cardiac
assist devices (pp. 183-192). Armonk, NY: Futura
Publishing Company, Inc.
Sunding, D., & Zivin, J. (2000). Insect population
dynamics, pesticide use and farmworker health. American
Journal of Agricultural Economics, 82, 527 540.
Gelijns, A., Graff Zivin, J., & Nelson, R. (2001).
Uncertainty and technological change in medicine.
Journal of Health Politics, Policy, and Law, 26, 913
924.
Graff Zivin, Joshua (2001). Cost effectiveness analysis
with risk aversion. Health Economics, 10, 499 508.
Glied, S., & Graff Zivin, J. (2002). How do doctors
behave when some (but not all) of their patients are in
managed care? Journal of Health Economics, 21, 337 353.
Glied, S., Remler, D., & Graff Zivin, J. (2002). Inside
the sausage factory: improving estimates of the effects
of health insurance expansion proposals. Milbank
Quarterly, 80, 603 635.
Graff Zivin, J., & Bridges, J. (2002). Addressing risk
preferences in cost effectiveness analyses. Applied
Health Economics and Health Policy, 1, 135 139.
Graff Zivin, J., Small, A.A. (2003). Risk sharing in
Coasean contracts. Journal of Environmental Economics
and Management, 45, 394 415.
Graff Zivin, J., & Sunding, D. (2002). A comparison of
policies to reduce pesticide poisoning combining
economic and toxicological data. In D. Hall, & J.
Moffit (Eds.), Advances in the economics of
environmental resources. (Vol. 4). New York: Elsevier
Science Ltd.
Graff Zivin, J., & Zilberman, D. (2002). Optimal
environmental health regulations with heterogeneous
populations: Treatment versus "tagging." Journal of
Environmental Economics and Management, 43, 455 476.
Khan, K., Muennig, P., Behta, M., & Graff Zivin, J.
(2002). Globalization and infectious diseases:
Integrating country of origin into the clinical
management of latent tuberculosis infection. New
England Journal of Medicine, 347, 1850 1859.
Glied, S., Remler, D., & Graff Zivin, J. (2003). Inside
the sausage factory: improving estimates of the effects
of health insurance expansion proposals: Reply. Milbank
Quarterly 81,165 167.
Khan, K., Muennig, P., & Graff Zivin, J. (2003).
Management of latent tuberculosis infection in
immigrants: Reply. New England Journal of Medicine,
348, 1291-1292.
Mojtabai, R., & Graff Zivin, J. (2003). Effectiveness
and cost effectiveness of four treatment modalities for
substance disorders: A propensity score analysis.
Health Services Research, 38, 233 259.
Graff Zivin, J., & Pfaff, A. (2004). To err on humans
is not benign: Incentives for adoption of medical error
reporting systems. Journal of Health Economics, 23,
935-949.
Remler, D., Graff Zivin, J., & Glied, S. (2004).
Modeling health insurance expansions: Effects of
alternate approaches. Journal of Policy Analysis and
Management, 23, 291-313.
Shih, C., Graff Zivin, J., Trokel, S., Tsai, J. (2004).
Clinical impact of central corneal thickness in the
management of glaucoma. Archives of Ophthalmology, 122,
1270-1275.
Angevine, P., Graff Zivin, J., & McCormick, P. (2005).
Cost-effectiveness of single-level anterior cervical
discectomy and fusion for cervical spondylosis. Spine,
30, 1989-1997.
Khan, K., Muennig, P., Gardam, M., & Graff Zivin, J.
(2005). Optimizing clinical management of febrile
respiratory illness during a SARS outbreak in
respiratory season. Emerging Infectious Diseases, 11,
191-200.
Leonard, K., & Graff Zivin, J. (2005). Outcome versus
service based payments in health care: Lessons from
African traditional healers. Health Economics, 14,
575-593.
Anderson, K., Jacobson, J., Heitjan, D., Graff Zivin,
J., Hershman, D., Neugut, A., & Grann, V. (2006).
Cost-effectiveness of preventive strategies for women
with a BRCA1 or a BRCA2 mutation. Annals of Internal
Medicine, 6, 397-406.
Graff Zivin, J. (2006). Ensuring a safe food supply:
The importance of heterogeneity. Journal of
Agricultural and Food Industrial Organization, 4,
1119-1119.
Graff Zivin, J., Just, R., & Zilberman, D. (2006). Risk
aversion, liability rules, and safety. International
Review of Law and Economics, 4, 604-623. |
